Head and Neck Cancer

HEAD AND NECK CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

The Twitter Effect on How Oncologists Conduct and Share Research

The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
Gardasil 9 for the Prevention of Some Head and Neck Cancers: Measuring the Benefit

The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval.
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials

It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
Conflicts of Interest Continue to Plague Oncology Guidelines and Research

New research presented at ASCO 2020 sheds light on conflicts of interest among NCCN panelists and links industry dollars to measures of academic success among junior faculty.
Why Cancer Centers May Need to Rethink the Hard Sell to Patients

Two recent papers are encouraging cancer center executives to rethink how they position their services to potential patients.

HEAD AND NECK CANCER NEWS

Experts Establish Surgical Priority Ranking for Head and Neck Cancers

September 10, 2020

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.

Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer

August 25, 2020

Evaluating a patient's weight loss.

Weight and Swallowing-Related Quality of Life in Patients Treated for Oropharyngeal Cancer

August 21, 2020

Adding Radiotherapy to Chemotherapy Boosts Survival in Nasopharyngeal Carcinoma

August 6, 2020

Approximately half of patients with advanced cancer who are enrolled in phase 1 clinical trials do n

A 6-Gene Expression Signature May Predict Benefit From Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer

August 6, 2020

Next post in Head and Neck Cancer

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.

Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer